TET2 c.-46-6832A>G

Variant ID: 4-106148222-A-G

NM_001127208.2(TET2):c.-46-6832A>G

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Magnetic Resonance Imaging-Guided vs Computed Tomography-Guided Stereotactic Body Radiotherapy for Prostate Cancer: The MIRAGE Randomized Clinical Trial.

Jama Oncology
Kishan, Amar U AU; Ma, Ting Martin TM; Lamb, James M JM; Casado, Maria M; Wilhalme, Holly H; Low, Daniel A DA; Sheng, Ke K; Sharma, Sahil S; Nickols, Nicholas G NG; Pham, Jonathan J; Yang, Yingli Y; Gao, Yu Y; Neylon, John J; Basehart, Vincent V; Cao, Minsong M; Steinberg, Michael L ML
Publication Date: 2023-01-12

Variant appearance in text: rs13143564
PubMed Link: 36633877
Variant Present in the following documents:
  • Main text
View BVdb publication page



Evaluation of T2-Weighted MRI for Visualization and Sparing of Urethra with MR-Guided Radiation Therapy (MRgRT) On-Board MRI.

Cancers
Pham, Jonathan J; Savjani, Ricky R RR; Gao, Yu Y; Cao, Minsong M; Hu, Peng P; Sheng, Ke K; Low, Daniel A DA; Steinberg, Michael M; Kishan, Amar U AU; Yang, Yingli Y
Publication Date: 2021-07-16

Variant appearance in text: rs13143564
PubMed Link: 34298777
Variant Present in the following documents:
  • Main text
  • cancers-13-03564.pdf
View BVdb publication page